Rizatriptan Receives FDA Approval

The generic equivalent of Merck’s Maxalt tablets, Rizatriptan Benzoate, indicated for the acute treatment of migraine has just been approved by the Federal Drug Administration. India based Aurobindo Pharma has received final approval to manufacture and market Rizatriptan 5mg and 10mg tablets. The company says they are ready to launch the medication….. Express Pharma 1/2/13